新型查尔酮酰胺α-葡萄糖苷酶抑制剂的设计、合成和抑制评估。

IF 3.2 4区 医学 Q3 CHEMISTRY, MEDICINAL Future medicinal chemistry Pub Date : 2024-07-02 Epub Date: 2024-05-22 DOI:10.1080/17568919.2024.2347092
Song Yao Lv, Li Ping Cheng
{"title":"新型查尔酮酰胺α-葡萄糖苷酶抑制剂的设计、合成和抑制评估。","authors":"Song Yao Lv, Li Ping Cheng","doi":"10.1080/17568919.2024.2347092","DOIUrl":null,"url":null,"abstract":"<p><p><b>Aim:</b> The purpose of this study is to design and synthesize a series of novel chalcone amide α-glucosidase (AG) inhibitors (<b>L1-L10</b>) based on virtual screening and molecular dynamics (MD) simulation. <b>Materials & methods:</b> Target compounds (<b>L1-L10</b>) were synthesized from 2-hydroxyacetophenone and methyl 4-formylbenzoate. <b>Results:</b> <i>In vitro</i> activity test shows that most compounds have good AG inhibition. Specially, compound <b>L4</b> (IC<sub>50</sub> = 8.28 ± 0.04 μM) had the best inhibitory activity, superior to positive control acarbose (IC<sub>50</sub> = 8.36 ± 0.02 μM). Molecular docking results show that the good potency of <b>L4</b> maybe attributed to strong interactions between chalcone skeleton and active site, and the torsion of carbon nitrogen bond in amide group. <b>Conclusion:</b> Compound <b>L4</b> maybe regard as a good anti-Type II diabetes candidate to preform further study.</p>","PeriodicalId":12475,"journal":{"name":"Future medicinal chemistry","volume":"16 13","pages":"1333-1345"},"PeriodicalIF":3.2000,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318676/pdf/","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors.\",\"authors\":\"Song Yao Lv, Li Ping Cheng\",\"doi\":\"10.1080/17568919.2024.2347092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Aim:</b> The purpose of this study is to design and synthesize a series of novel chalcone amide α-glucosidase (AG) inhibitors (<b>L1-L10</b>) based on virtual screening and molecular dynamics (MD) simulation. <b>Materials & methods:</b> Target compounds (<b>L1-L10</b>) were synthesized from 2-hydroxyacetophenone and methyl 4-formylbenzoate. <b>Results:</b> <i>In vitro</i> activity test shows that most compounds have good AG inhibition. Specially, compound <b>L4</b> (IC<sub>50</sub> = 8.28 ± 0.04 μM) had the best inhibitory activity, superior to positive control acarbose (IC<sub>50</sub> = 8.36 ± 0.02 μM). Molecular docking results show that the good potency of <b>L4</b> maybe attributed to strong interactions between chalcone skeleton and active site, and the torsion of carbon nitrogen bond in amide group. <b>Conclusion:</b> Compound <b>L4</b> maybe regard as a good anti-Type II diabetes candidate to preform further study.</p>\",\"PeriodicalId\":12475,\"journal\":{\"name\":\"Future medicinal chemistry\",\"volume\":\"16 13\",\"pages\":\"1333-1345\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2024-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11318676/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Future medicinal chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/17568919.2024.2347092\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/22 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future medicinal chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17568919.2024.2347092","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:本研究旨在基于虚拟筛选和分子动力学(MD)模拟,设计并合成一系列新型查尔酮酰胺类α-葡萄糖苷酶(AG)抑制剂(L1-L10)。材料与方法:目标化合物(L1-L10)由 2-羟基苯乙酮和 4-甲酰基苯甲酸甲酯合成。结果体外活性测试表明,大多数化合物具有良好的 AG 抑制作用。其中,化合物 L4(IC50 = 8.28 ± 0.04 μM)的抑制活性最好,优于阳性对照阿卡波糖(IC50 = 8.36 ± 0.02 μM)。分子对接结果表明,L4 的良好效力可能归因于查尔酮骨架与活性位点之间的强相互作用,以及酰胺基团中碳氮键的扭转。结论化合物 L4 可能是一种很好的抗 II 型糖尿病候选化合物,有待进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Design, synthesis and inhibition evaluation of novel chalcone amide α-glucosidase inhibitors.

Aim: The purpose of this study is to design and synthesize a series of novel chalcone amide α-glucosidase (AG) inhibitors (L1-L10) based on virtual screening and molecular dynamics (MD) simulation. Materials & methods: Target compounds (L1-L10) were synthesized from 2-hydroxyacetophenone and methyl 4-formylbenzoate. Results: In vitro activity test shows that most compounds have good AG inhibition. Specially, compound L4 (IC50 = 8.28 ± 0.04 μM) had the best inhibitory activity, superior to positive control acarbose (IC50 = 8.36 ± 0.02 μM). Molecular docking results show that the good potency of L4 maybe attributed to strong interactions between chalcone skeleton and active site, and the torsion of carbon nitrogen bond in amide group. Conclusion: Compound L4 maybe regard as a good anti-Type II diabetes candidate to preform further study.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Future medicinal chemistry
Future medicinal chemistry CHEMISTRY, MEDICINAL-
CiteScore
5.80
自引率
2.40%
发文量
118
审稿时长
4-8 weeks
期刊介绍: Future Medicinal Chemistry offers a forum for the rapid publication of original research and critical reviews of the latest milestones in the field. Strong emphasis is placed on ensuring that the journal stimulates awareness of issues that are anticipated to play an increasingly central role in influencing the future direction of pharmaceutical chemistry. Where relevant, contributions are also actively encouraged on areas as diverse as biotechnology, enzymology, green chemistry, genomics, immunology, materials science, neglected diseases and orphan drugs, pharmacogenomics, proteomics and toxicology.
期刊最新文献
A comprehensive insight into naphthalimides as novel structural skeleton of multitargeting promising antibiotics. A call to develop tramadol enantiomer for overcoming the tramadol crisis by reducing addiction. Advancements in PROTAC-based therapies for neurodegenerative diseases. EGFR molecular degraders: preclinical successes and the road ahead. How does machine learning augment alchemical binding free energy calculations?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1